Analyst Conference Summaries

Biotechnology Investor Aids

Ionis Pharmaceuticals

I plan to being coverage of Ionis with the Q2 2017 conference call. I own stock in a rival, Alnylam Pharmaceuticals (ALNY).

conference date: not yet scheduled




O (O) is a -stage biotechnology company specializing in

Ionis Pharmaceuticals web site

Ionis Pharmaceuticals investor relations



More Analyst Conference Pages:


Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.

Copyright 2017 William P. Meyers